Our Mission

To translate aging biology into treatments that profoundly rejuvenate the immune system and enhance human longevity.

Leadership

Meet Our Team

Greg Fahy, PhD

Chief Scientific Officer

Led the TRIIM trial. 40+ years in cryobiology and aging research.

Robert Brooke

CEO & CTO

Co-founder of Clock Foundation and Intervene Immune. TRIIM regulatory lead.

Steve Horvath, PhD

Scientific Collaborator

UCLA Professor. Creator of the epigenetic clock.

Grace Dyer

Director, Trial Operations

Participant coordination and study logistics.

Shreyas Vasanawala, MD, PhD

Medical Advisor

Stanford Radiology Professor. MRI imaging pioneer.

Joseph Scherger, MD, MPH

TRIIM-X Trial Physician

VP of Primary Care at Eisenhower Health. Healthy aging expert.

Ulalume Hernandez-Arciga, PhD

Research Scientist

Immunology & aging researcher.

Paul Hynek, MBA

Chief Financial Officer

Wharton MBA. TRIIM trial volunteer and early believer.

Thought Leaders

Decades of Groundbreaking Research

Dr. Greg Fahy's pioneering work on thymus regeneration and Dr. Steve Horvath's revolutionary epigenetic clocks represent two of the most significant advances in aging biology. Their collaboration at Intervene Immune brings together complementary expertise to measure and reverse biological aging.

The TRIIM trial demonstrated for the first time that it's possible to reverse epigenetic age in humans—a finding that has reshaped how we understand aging interventions.

Research & Publications